Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 35 (3-4), 459-483
- https://doi.org/10.1080/08820130600803429
Abstract
The fact that the immune response to cancer is compromised has been convincingly demonstrated in murine tumor models as well as in cancer patients. The unresponsiveness of the host immune system is one of the major mechanisms of tumor escape as well as an important factor that limits the success of cancer immunotherapy. Inadequate function of professional antigen presenting cells dendritic cells (DC) in cancer is one of the major elements of compromised anti-tumor immune response. Despite substantial progress in recent years, the mechanism of inadequate DC function in cancer still remains unclear. The tumor microenvironment has emerged as an important component contributing to DC malfunction. In this review we will discuss the potential role of tumor microenvironment in DC dysfunction.Keywords
This publication has 176 references indexed in Scilit:
- Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathwaysBiochemical and Biophysical Research Communications, 2005
- Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8International Journal of Cancer, 2005
- Soluble factors involved in glioma invasionActa Neurochirurgica, 2003
- Inflammation and cancerNature, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Angiogenesis and metastasisEuropean Journal Of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Redox modulation of tyrosine phosphorylation-dependent signal transduction pathwaysFree Radical Biology & Medicine, 1996
- Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cellsCancer Immunology, Immunotherapy, 1991